# Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

> **NCT01506336** · PHASE2 · COMPLETED · sponsor: **AB Science** · enrollment: 44 (actual)

## Conditions studied

- Gastro Intestinal Stromal Tumor

## Interventions

- **DRUG:** masitinib
- **DRUG:** sunitinib

## Key facts

- **NCT ID:** NCT01506336
- **Lead sponsor:** AB Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-09
- **Final completion:** 2012-04
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01506336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01506336, "Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT01506336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*